Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Med Sci Sports Exerc. 2014 Jun;46(6):1104–1113. doi: 10.1249/MSS.0000000000000206

Table 2.

Physiological variables measured at baseline, during warmup exercise, and during exercise-to-exhaustion in control and asthmatic subjects.

Exercise-to-exhaustion
Baseline Warmup 1 min 3 min End Recovery
Control Group (n=9)
VO2, L·min−1
  Control trial 0.42 ± 0.1 2.7 ± 0.6 3.1 ± 0.6 3.3 ± 0.6 3.6 ± 0.9 0.67 ± 0.2
  BD trial 0.40 ± 0.1 2.6 ± 0.5 3.0 ± 0.6 3.2 ± 0.6 3.4 ± 0.7 0.65 ± 0.2
  SHAM trial 0.40 ± 0.1 2.6 ± 0.4 3.0 ± 0.7 3.2 ± 0.7 3.5 ± 0.9 0.63 ± 0.2
  BC trial 0.40 ± 0.1 2.6 ± 0.5 3.0 ± 0.7 3.2 ± 0.7 3.6 ± 0.9 0.77 ± 0.3
Ve/VO2
  Control trial 35.0 ± 16.3 24.9 ± 4.8 26.1 ± 5.8 29.5 ± 6.4 34.1 ± 7.7 47.3 ± 14.9
  BD trial 36.5 ± 10.0 25.2 ± 4.4 26.7 ± 4.2 29.3 ± 4.9 34.3 ± 6.0 45.9 ± 8.4
  SHAM trial 36.3 ± 9.4 25.3 ± 4.6 26.8 ± 5.0 29.3 ± 5.0 34.5 ± 5.5 47.3 ± 8.5
  BC trial 39.6 ± 11.1 25.3 ± 3.3 27.2 ± 4.3 29.9 ± 4.4 34.5 ± 5.5 45.6 ± 5.5
HR, BPM
  Control trial 71.7 ± 9 140.2 ± 14 156.9 ± 12 167.7 ± 11 177.0 ± 8 113.1 ± 9
  BD trial 80.4 ± 13 144.0 ± 12 158.7 ± 12 169.1 ± 8 177.6 ± 8 113.0 ± 11
  SHAM trial 73.8 ± 7 144.1 ± 12 158.8 ± 12 168.6 ± 11 178.1 ± 12 113.7 ± 17
  BC trial 72.0 ± 6 139.8 ± 11 157.4 ± 9 167.8 ± 9 177.4 ± 11 111.2 ± 13
RPE, Breath
  Control trial 0.28 ± 0.44 1.39 ± 1.02 2.78 ± 1.09 4.78 ± 1.20 7.44 ± 1.59 3.33 ± 1.98
  BD trial 0.17 ± 0.35 1.17 ± 0.71 2.50 ± 1.00 4.89 ± 1.27 7.67 ± 1.94 3.78 ± 1.92
  SHAM trial 0.33 ± 0.71 1.56 ± 0.98 3.22 ± 0.83 5.00 ± 1.12 8.33 ± 1.73 4.22 ± 2.22
  BC trial 0.22 ± 0.44 1.33 ± 0.97 3.44 ± 1.01 4.89 ± 1.83 8.22 ± 1.39 3.33 ± 1.66
RPE, Legs
  Control trial 0.17 ± 0.25 2.17 ± 1.52 4.44 ± 1.67 6.00 ± 1.22 9.44 ± 0.73 5.28 ± 2.41
  BD trial 0.17 ± 0.25 2.39 ± 2.00 3.78 ± 1.92 6.06 ± 1.51 8.89 ± 1.05 5.00 ± 2.12
  SHAM trial 0.17 ± 0.35 2.22 ± 1.37 4.11 ± 1.45 6.11 ± 1.17 9.22 ± 1.09 5.33 ± 2.65
  BC trial 0.06 ± 0.17 2.56 ± 1.51 4.56 ± 0.88 6.44 ± 1.33 9.22 ± 1.30 5.00 ± 2.00
Asthma Group (n=8)
VO2, L·min−1
  Control trial 0.40 ± 0.1 2.6 ± 0.4 2.8 ± 0.6 3.1 ± 0.6 3.3 ± 0.7 0.71 ± 0.2
  BD trial 0.50 ± 0.2 2.7 ± 0.4 2.8 ± 0.5 3.1 ± 0.7 3.4 ± 0.6 0.81 ± 0.2
  SHAM trial 0.50 ± 0.2 2.5 ± 0.6 2.7 ± 0.6 3.0 ± 0.7 3.3 ± 0.8 0.69 ± 0.2
  BC trial 0.40 ± 0.1 2.5 ± 0.5 2.8 ± 0.5 3.1 ± 0.7 3.2 ± 0.7 0.69 ± 0.2
Ve/VO2
  Control trial 39.4 ± 7.8 28.2 ± 3.3 30.9 ± 3.5 35.0 ± 5.6 37.6 ± 7.6 48.7 ± 5.0
  BD trial 35.0 ± 10.1 27.7 ± 4.5 30.5 ± 6.1 33.1 ± 7.2 36.0 ± 6.6 42.5 ± 9.2
  SHAM trial 36.1 ± 12.2 28.5 ± 4.0 31.9 ± 5.2 32.7 ± 4.2 38.4 ± 7.1 50.0 ± 4.3
  BC trial 37.2 ± 8.0 29.2 ± 3.1 31.4 ± 3.5 33.4 ± 4.9 36.8 ± 6.3 46.7 ± 6.2
HR, BPM
  Control trial 74.0 ± 13 136.5 ± 14 151.8 ± 11 165.0 ± 13 173.3 ± 12 110.8 ± 17
  BD trial 81.1 ± 16 142.1 ± 15 156.9 ± 13 167.1 ± 13 173.6 ± 13 117.3 ± 18
  SHAM trial 72.3 ± 9 139.4 ± 16 154.9 ± 14 165.9 ± 14 172.3 ± 13 112.8 ± 19
  BC trial 75.3 ± 13 139.6 ± 14 154.4 ± 13 164.7 ± 13 168.4 ± 13 114.1 ± 28
RPE, Breath
  Control trial 0.25 ± 0.27 1.50 ± 1.28 3.00 ± 1.85 5.13 ± 2.46 7.88 ± 1.96 3.31 ± 2.69
  BD trial 0.19 ± 0.26 2.50 ± 1.41 4.13 ± 2.10 5.57 ± 2.70 7.81 ± 3.21 3.19 ± 2.00
  SHAM trial 0.31 ± 0.70 2.19 ± 1.13a 3.56 ± 1.45 5.50 ± 1.93 7.63 ± 2.13 3.00 ± 1.77
  BC trial 0.69 ± 1.36 2.13 ± 1.55 4.00 ± 2.14 5.38 ± 2.67 7.31 ± 3.08 3.88 ± 3.04
RPE, Legs
  Control trial 0.19 ± 0.26 2.19 ± 1.46 3.88 ± 1.64 6.50 ± 2.00 8.63 ± 1.51 3.14 ± 2.12
  BD trial 0.13 ± 0.23 2.88 ± 1.73 4.81 ± 2.10 6.31 ± 2.22 8.13 ± 1.64 2.71 ± 2.48
  SHAM trial 0.13 ± 0.23 2.94 ± 1.43 4.25 ± 1.58 6.25 ± 1.89 8.00 ± 2.27 2.75 ± 1.16
  BC trial 0.13 ± 0.23 2.50 ± 1.77 4.56 ± 2.38 5.69 ± 2.52 8.38 ± 1.69 3.50 ± 1.93

VO2, oxygen consumption; Ve/VO2, ventilatory equivalent for oxygen consumption; RPE, rating of perceived exertion. a, p<0.05 vs. control trial